Nexium DR 20 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6X7S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,663
Award facts
- Contract value 100% obligated
- $2,663.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,663.38 to AmerisourceBergen Drug Corp for the supply of Nexium DR 20 mg capsule 90-count units. The contract was awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which serves as the parent organization.
The delivery of Nexium, a proton pump inhibitor used to treat gastroesophageal reflux disease and related gastrointestinal conditions, supports the DLA Medical Supply Chain's mission to provide essential pharmaceutical products to military healthcare systems and other federal medical institutions. AmerisourceBergen's extensive IDC with DLA enables the company to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military treatment facilities, veterans' healthcare programs, and other government healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26F6X7S?
SPE2DR26F6X7S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6X7S worth?
The government has obligated $2,663 on SPE2DR26F6X7S.
Is contract SPE2DR26F6X7S an order under another contract?
Yes. SPE2DR26F6X7S is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X7S competed?
The extent of competition for SPE2DR26F6X7S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award